Background/Aim: The aim of this study was to assess the feasibility and safety of
hypofractionated carbon-ion radiotherapy (C-ion RT) in patients with stage III non-small cell …

Introduction: In 1994, we started carbon-ion radiotherapy (CIRT) for peripheral stage I non-
small-cell lung cancer (NSCLC). First, two phase I/II clinical trials demonstrated the optimal …

This phase II study's aim was to confirm the efficacy and safety of hypofractionated carbon‐
ion radiotherapy in patients with stage I peripheral nonsmall cell lung cancer (NSCLC). The …

Purpose: A phase I/II study on carbon ion radiotherapy for Stage I non–small-cell lung
cancer (NSCLC) was first conducted between 1994 and 1999 and determined the optimal …

BACKGROUND Although concurrent chemoradiotherapy (CCRT) has become the standard
approach for unresectable locally advanced non–small cell lung cancer (LA‐NSCLC), most …

Background A phase I/II study was first conducted for the treatment of stage I non-small cell
lung cancer (NSCLC) from 1994 to 1999 to determine the optimal dose. On the basis on the …

Backgroundandpurpose: Heavy ion radiotherapy is a promising modality because of its
excellent dose localization and high biological effect on tumors. Using carbon beams, a …

Carbon-ion radiation therapy (CIRT) for advanced non–small-cell lung cancer (NSCLC) has
not been well studied to date. This paper aimed to analyze a retrospective multicenter …

Simple Summary There were no reports on long-term results of single-fraction passive
carbon-ion radiotherapy in patients with early-stage non-small cell lung cancer. We showed …

Background and purpose Radiotherapy is a standard treatment for inoperable stage I non-
small cell lung cancer (NSCLC), and carbon-ion radiation therapy (CIRT) may be used for …